APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fecal Microbiota Transplantation（FMT）

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Fecal Microbiota Transplantation（FMT） Market Outlook and Growth Opportunities 2026

15 January 2026198 pages

Choose your research edition.

Industry ResearchFecal Microbiota Transplantation（FMT） Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Fecal Microbiota Transplantation（FMT） Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Fecal Microbiota Transplantation（FMT） Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fecal Microbiota Transplantation（FMT） Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Fecal Microbiota Transplantation（FMT） Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Fecal Microbiota Transplantation（FMT） market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Fecal Microbiota Transplantation（FMT） is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Fecal Microbiota Transplantation（FMT） is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fecal Microbiota Transplantation（FMT） is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Fecal Microbiota Transplantation（FMT） market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Fecal Microbiota Transplantation（FMT） market include OpenBiome, Ramon Y Cajal, Asia Microbiota Bank, Taymount Clinic, FMT Bank, Birmingham MTC, BiomeBank, GoldBiome and Johns Hopkins, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Fecal Microbiota Transplantation（FMT） market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fecal Microbiota Transplantation（FMT） and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fecal Microbiota Transplantation（FMT） revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Fecal Microbiota Transplantation（FMT） market.

Fecal Microbiota Transplantation（FMT） Segment by Company

OpenBiome

Ramon Y Cajal

Asia Microbiota Bank

Taymount Clinic

FMT Bank

Birmingham MTC

BiomeBank

GoldBiome

Johns Hopkins

Fecal Microbiota Transplantation（FMT） Segment by Type

Fermentation

Fresh

Cryopreservation

Fecal Microbiota Transplantation（FMT） Segment by Application

Intestinal Disease

Extraintestinal Disease

Other

Fecal Microbiota Transplantation（FMT） Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Fecal Microbiota Transplantation（FMT） status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Fecal Microbiota Transplantation（FMT） key companies, revenue, market share, and recent developments.

3. To split the Fecal Microbiota Transplantation（FMT） breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Fecal Microbiota Transplantation（FMT） market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Fecal Microbiota Transplantation（FMT） significant trends, drivers, influence factors in global and regions.

6. To analyze Fecal Microbiota Transplantation（FMT） competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fecal Microbiota Transplantation（FMT） market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fecal Microbiota Transplantation（FMT） and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fecal Microbiota Transplantation（FMT）.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Fecal Microbiota Transplantation（FMT） industry.

Chapter 3: Detailed analysis of Fecal Microbiota Transplantation（FMT） company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Fecal Microbiota Transplantation（FMT） in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Fecal Microbiota Transplantation（FMT） in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Fecal Microbiota Transplantation（FMT） Industry Trends Table 2. Fecal Microbiota Transplantation（FMT） Industry Drivers Table 3. Fecal Microbiota Transplantation（FMT） Industry Opportunities and Challenges Table 4. Fecal Microbiota Transplantation（FMT） Industry Restraints Table 5. Global Fecal Microbiota Transplantation（FMT） Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Fecal Microbiota Transplantation（FMT） Revenue Share by Company (2021-2026) Table 7. Global Fecal Microbiota Transplantation（FMT） Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Fecal Microbiota Transplantation（FMT） Key Company Manufacturing Base & Headquarters Table 9. Global Fecal Microbiota Transplantation（FMT） Company, Product Type & Application Table 10. Global Fecal Microbiota Transplantation（FMT） Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Fecal Microbiota Transplantation（FMT） by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Fermentation Table 15. Significant Companies of Fresh Table 16. Significant Companies of Cryopreservation Table 17. Global Fecal Microbiota Transplantation（FMT） Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Fecal Microbiota Transplantation（FMT） Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Fecal Microbiota Transplantation（FMT） Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Fecal Microbiota Transplantation（FMT） Sales Value Share by Type (2021-2026) Table 21. Global Fecal Microbiota Transplantation（FMT） Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Intestinal Disease Table 23. Significant Companies of Extraintestinal Disease Table 24. Significant Companies of Other Table 25. Global Fecal Microbiota Transplantation（FMT） Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Fecal Microbiota Transplantation（FMT） Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Fecal Microbiota Transplantation（FMT） Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Fecal Microbiota Transplantation（FMT） Sales Value Share by Application (2021-2026) Table 29. Global Fecal Microbiota Transplantation（FMT） Sales Value Share by Application (2027-2032) Table 30. Global Fecal Microbiota Transplantation（FMT） Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Fecal Microbiota Transplantation（FMT） Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Fecal Microbiota Transplantation（FMT） Sales Value Share by Region (2021-2026) Table 33. Global Fecal Microbiota Transplantation（FMT） Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Fecal Microbiota Transplantation（FMT） Sales Value Share by Region (2027-2032) Table 35. Global Fecal Microbiota Transplantation（FMT） Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Fecal Microbiota Transplantation（FMT） Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Fecal Microbiota Transplantation（FMT） Sales Value Market Share by Country (2021-2026) Table 38. Global Fecal Microbiota Transplantation（FMT） Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Fecal Microbiota Transplantation（FMT） Sales Value Market Share by Country (2027-2032) Table 40. OpenBiome Company Information Table 41. OpenBiome Business Overview Table 42. OpenBiome Fecal Microbiota Transplantation（FMT） Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. OpenBiome Fecal Microbiota Transplantation（FMT） Product Portfolio Table 44. OpenBiome Recent Development Table 45. Ramon Y Cajal Company Information Table 46. Ramon Y Cajal Business Overview Table 47. Ramon Y Cajal Fecal Microbiota Transplantation（FMT） Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Ramon Y Cajal Fecal Microbiota Transplantation（FMT） Product Portfolio Table 49. Ramon Y Cajal Recent Development Table 50. Asia Microbiota Bank Company Information Table 51. Asia Microbiota Bank Business Overview Table 52. Asia Microbiota Bank Fecal Microbiota Transplantation（FMT） Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Asia Microbiota Bank Fecal Microbiota Transplantation（FMT） Product Portfolio Table 54. Asia Microbiota Bank Recent Development Table 55. Taymount Clinic Company Information Table 56. Taymount Clinic Business Overview Table 57. Taymount Clinic Fecal Microbiota Transplantation（FMT） Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Taymount Clinic Fecal Microbiota Transplantation（FMT） Product Portfolio Table 59. Taymount Clinic Recent Development Table 60. FMT Bank Company Information Table 61. FMT Bank Business Overview Table 62. FMT Bank Fecal Microbiota Transplantation（FMT） Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. FMT Bank Fecal Microbiota Transplantation（FMT） Product Portfolio Table 64. FMT Bank Recent Development Table 65. Birmingham MTC Company Information Table 66. Birmingham MTC Business Overview Table 67. Birmingham MTC Fecal Microbiota Transplantation（FMT） Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Birmingham MTC Fecal Microbiota Transplantation（FMT） Product Portfolio Table 69. Birmingham MTC Recent Development Table 70. BiomeBank Company Information Table 71. BiomeBank Business Overview Table 72. BiomeBank Fecal Microbiota Transplantation（FMT） Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. BiomeBank Fecal Microbiota Transplantation（FMT） Product Portfolio Table 74. BiomeBank Recent Development Table 75. GoldBiome Company Information Table 76. GoldBiome Business Overview Table 77. GoldBiome Fecal Microbiota Transplantation（FMT） Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. GoldBiome Fecal Microbiota Transplantation（FMT） Product Portfolio Table 79. GoldBiome Recent Development Table 80. Johns Hopkins Company Information Table 81. Johns Hopkins Business Overview Table 82. Johns Hopkins Fecal Microbiota Transplantation（FMT） Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Johns Hopkins Fecal Microbiota Transplantation（FMT） Product Portfolio Table 84. Johns Hopkins Recent Development Table 85. Research Programs/Design for This Report Table 86. Authors List of This Report Table 87. Secondary Sources Table 88. Primary Sources List of Figures Figure 1. Fecal Microbiota Transplantation（FMT） Product Image Figure 2. Global Fecal Microbiota Transplantation（FMT） Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fecal Microbiota Transplantation（FMT） Market Size (2021-2032) & (US$ Million) Figure 4. Global Fecal Microbiota Transplantation（FMT） Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Fermentation Image Figure 8. Fresh Image Figure 9. Cryopreservation Image Figure 10. Global Fecal Microbiota Transplantation（FMT） Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Fecal Microbiota Transplantation（FMT） Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Fecal Microbiota Transplantation（FMT） Sales Value Share by Type (2021-2032) Figure 13. Intestinal Disease Image Figure 14. Extraintestinal Disease Image Figure 15. Other Image Figure 16. Global Fecal Microbiota Transplantation（FMT） Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Fecal Microbiota Transplantation（FMT） Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Fecal Microbiota Transplantation（FMT） Sales Value Share by Application (2021-2032) Figure 19. Global Fecal Microbiota Transplantation（FMT） Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Fecal Microbiota Transplantation（FMT） Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Fecal Microbiota Transplantation（FMT） Sales Value (2021-2032) & (US$ Million) Figure 22. North America Fecal Microbiota Transplantation（FMT） Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Fecal Microbiota Transplantation（FMT） Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Fecal Microbiota Transplantation（FMT） Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Fecal Microbiota Transplantation（FMT） Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Fecal Microbiota Transplantation（FMT） Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Fecal Microbiota Transplantation（FMT） Sales Value (2021-2032) & (US$ Million) Figure 28. South America Fecal Microbiota Transplantation（FMT） Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Fecal Microbiota Transplantation（FMT） Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Fecal Microbiota Transplantation（FMT） Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Fermentation
  • Fresh
  • Cryopreservation
Applications
  • Intestinal Disease
  • Extraintestinal Disease
  • Other
Companies covered
  • OpenBiome
  • Ramon Y Cajal
  • Asia Microbiota Bank
  • Taymount Clinic
  • FMT Bank
  • Birmingham MTC
  • BiomeBank
  • GoldBiome
  • Johns Hopkins

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Fecal Microbiota Transplantation（FMT） Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Fecal Microbiota Transplantation（FMT） Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Fecal Microbiota Transplantation（FMT） Market Dynamics
  1. 2.1 Fecal Microbiota Transplantation（FMT） Industry Trends
  2. 2.2 Fecal Microbiota Transplantation（FMT） Industry Drivers
  3. 2.3 Fecal Microbiota Transplantation（FMT） Industry Opportunities and Challenges
  4. 2.4 Fecal Microbiota Transplantation（FMT） Industry Restraints
3 Fecal Microbiota Transplantation（FMT） Market by Company
  1. 3.1 Global Fecal Microbiota Transplantation（FMT） Company Revenue Ranking in 2025
  2. 3.2 Global Fecal Microbiota Transplantation（FMT） Revenue by Company (2021-2026)
  3. 3.3 Global Fecal Microbiota Transplantation（FMT） Company Ranking (2024-2026)
  4. 3.4 Global Fecal Microbiota Transplantation（FMT） Company Manufacturing Base and Headquarters
  5. 3.5 Global Fecal Microbiota Transplantation（FMT） Company Product Type and Application
  6. 3.6 Global Fecal Microbiota Transplantation（FMT） Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Fecal Microbiota Transplantation（FMT） Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Fecal Microbiota Transplantation（FMT） Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Fecal Microbiota Transplantation（FMT） Market by Type
  1. 4.1 Fecal Microbiota Transplantation（FMT） Type Introduction
  2. 4.1.1 Fermentation
  3. 4.1.2 Fresh
  4. 4.1.3 Cryopreservation
  5. 4.2 Global Fecal Microbiota Transplantation（FMT） Sales Value by Type
  6. 4.2.1 Global Fecal Microbiota Transplantation（FMT） Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Fecal Microbiota Transplantation（FMT） Sales Value by Type (2021-2032)
  8. 4.2.3 Global Fecal Microbiota Transplantation（FMT） Sales Value Share by Type (2021-2032)
5 Fecal Microbiota Transplantation（FMT） Market by Application
  1. 5.1 Fecal Microbiota Transplantation（FMT） Application Introduction
  2. 5.1.1 Intestinal Disease
  3. 5.1.2 Extraintestinal Disease
  4. 5.1.3 Other
  5. 5.2 Global Fecal Microbiota Transplantation（FMT） Sales Value by Application
  6. 5.2.1 Global Fecal Microbiota Transplantation（FMT） Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Fecal Microbiota Transplantation（FMT） Sales Value by Application (2021-2032)
  8. 5.2.3 Global Fecal Microbiota Transplantation（FMT） Sales Value Share by Application (2021-2032)
6 Fecal Microbiota Transplantation（FMT） Regional Value Analysis
  1. 6.1 Global Fecal Microbiota Transplantation（FMT） Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fecal Microbiota Transplantation（FMT） Sales Value by Region (2021-2032)
  3. 6.2.1 Global Fecal Microbiota Transplantation（FMT） Sales Value by Region: 2021-2026
  4. 6.2.2 Global Fecal Microbiota Transplantation（FMT） Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Fecal Microbiota Transplantation（FMT） Sales Value (2021-2032)
  7. 6.3.2 North America Fecal Microbiota Transplantation（FMT） Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Fecal Microbiota Transplantation（FMT） Sales Value (2021-2032)
  10. 6.4.2 Europe Fecal Microbiota Transplantation（FMT） Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Fecal Microbiota Transplantation（FMT） Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Fecal Microbiota Transplantation（FMT） Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Fecal Microbiota Transplantation（FMT） Sales Value (2021-2032)
  16. 6.6.2 South America Fecal Microbiota Transplantation（FMT） Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Fecal Microbiota Transplantation（FMT） Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Fecal Microbiota Transplantation（FMT） Sales Value Share by Country, 2025 VS 2032
7 Fecal Microbiota Transplantation（FMT） Country-level Value Analysis
  1. 7.1 Global Fecal Microbiota Transplantation（FMT） Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Fecal Microbiota Transplantation（FMT） Sales Value by Country (2021-2032)
  3. 7.2.1 Global Fecal Microbiota Transplantation（FMT） Sales Value by Country (2021-2026)
  4. 7.2.2 Global Fecal Microbiota Transplantation（FMT） Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Fecal Microbiota Transplantation（FMT） Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Fecal Microbiota Transplantation（FMT） Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Fecal Microbiota Transplantation（FMT） Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 OpenBiome
  2. 8.1.1 OpenBiome Company Information
  3. 8.1.2 OpenBiome Business Overview
  4. 8.1.3 OpenBiome Fecal Microbiota Transplantation（FMT） Revenue and Gross Margin (2021-2026)
  5. 8.1.4 OpenBiome Fecal Microbiota Transplantation（FMT） Product Portfolio
  6. 8.1.5 OpenBiome Recent Developments
  7. 8.2 Ramon Y Cajal
  8. 8.2.1 Ramon Y Cajal Company Information
  9. 8.2.2 Ramon Y Cajal Business Overview
  10. 8.2.3 Ramon Y Cajal Fecal Microbiota Transplantation（FMT） Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ramon Y Cajal Fecal Microbiota Transplantation（FMT） Product Portfolio
  12. 8.2.5 Ramon Y Cajal Recent Developments
  13. 8.3 Asia Microbiota Bank
  14. 8.3.1 Asia Microbiota Bank Company Information
  15. 8.3.2 Asia Microbiota Bank Business Overview
  16. 8.3.3 Asia Microbiota Bank Fecal Microbiota Transplantation（FMT） Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Asia Microbiota Bank Fecal Microbiota Transplantation（FMT） Product Portfolio
  18. 8.3.5 Asia Microbiota Bank Recent Developments
  19. 8.4 Taymount Clinic
  20. 8.4.1 Taymount Clinic Company Information
  21. 8.4.2 Taymount Clinic Business Overview
  22. 8.4.3 Taymount Clinic Fecal Microbiota Transplantation（FMT） Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Taymount Clinic Fecal Microbiota Transplantation（FMT） Product Portfolio
  24. 8.4.5 Taymount Clinic Recent Developments
  25. 8.5 FMT Bank
  26. 8.5.1 FMT Bank Company Information
  27. 8.5.2 FMT Bank Business Overview
  28. 8.5.3 FMT Bank Fecal Microbiota Transplantation（FMT） Revenue and Gross Margin (2021-2026)
  29. 8.5.4 FMT Bank Fecal Microbiota Transplantation（FMT） Product Portfolio
  30. 8.5.5 FMT Bank Recent Developments
  31. 8.6 Birmingham MTC
  32. 8.6.1 Birmingham MTC Company Information
  33. 8.6.2 Birmingham MTC Business Overview
  34. 8.6.3 Birmingham MTC Fecal Microbiota Transplantation（FMT） Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Birmingham MTC Fecal Microbiota Transplantation（FMT） Product Portfolio
  36. 8.6.5 Birmingham MTC Recent Developments
  37. 8.7 BiomeBank
  38. 8.7.1 BiomeBank Company Information
  39. 8.7.2 BiomeBank Business Overview
  40. 8.7.3 BiomeBank Fecal Microbiota Transplantation（FMT） Revenue and Gross Margin (2021-2026)
  41. 8.7.4 BiomeBank Fecal Microbiota Transplantation（FMT） Product Portfolio
  42. 8.7.5 BiomeBank Recent Developments
  43. 8.8 GoldBiome
  44. 8.8.1 GoldBiome Company Information
  45. 8.8.2 GoldBiome Business Overview
  46. 8.8.3 GoldBiome Fecal Microbiota Transplantation（FMT） Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GoldBiome Fecal Microbiota Transplantation（FMT） Product Portfolio
  48. 8.8.5 GoldBiome Recent Developments
  49. 8.9 Johns Hopkins
  50. 8.9.1 Johns Hopkins Company Information
  51. 8.9.2 Johns Hopkins Business Overview
  52. 8.9.3 Johns Hopkins Fecal Microbiota Transplantation（FMT） Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Johns Hopkins Fecal Microbiota Transplantation（FMT） Product Portfolio
  54. 8.9.5 Johns Hopkins Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst